A New Treatment for Relapsing MS (RMS)

Multiple sclerosis (MS) is a neurological condition that impacts approximately 2.3 million people worldwide. Here today to with information about relapsing forms of MS (RMS) and a new treatment option, is Dr. Robert Shin, Professor of Neurology at Georgetown University and Director of the Georgetown Multiple Sclerosis and Neuroimmunology Center, and Kerry, a patient living with RMS.